Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that major-market sales of antiretroviral agents for HIV will decline slightly over the next decade, from an estimated $13.3 billion in 2011 to $12.9 billion in 2021 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Sales of antiretroviral agents for HIV will decline slightly over the next decade